|
⚲
|
| RCAF V CIV XIX LP | |
|---|---|
| Firm |
Riverside Partners LLC
✚
|
| Fund # | 805-7305168797 |
| CIK # | |
| Sale | |
| Fund | Private Equity Fund |
| Phone | |
| Address | |
| Source | [IAPD] |
| Fund AUM and Sold ($k) |
|---|
| Fund Details | |
|---|---|
| Director | RCAF V Associates LP |
| Custodian | JP Morgan Chase |
| Auditor | Deloitte LLP |
| Marketer | |
| Broker | |
| Jurisdiction |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Cancer Targeting Systems, Inc.
✚
|
0.0 | |
|
ATeams, Inc.
✚
|
0.0 | |
|
ATS 218, a series of SAX Capital Series Fund III, LP
✚
|
0.0 | |
|
AU Fund I, a series of 5 Eyes Ventures, LP
✚
|
0.0 | |
|
AU Fund I, a series of Matt Bilotti AL Funds, LP
✚
|
0.0 | |
|
AU Fund I, a series of Ride Wave Ventures, LP
✚
|
0.0 | |
|
SAB IV Financial Industries Partnership L.P.
✚
|
0.0 | |
|
Diameter Credit (BDC) Access LP
✚
|
0.0 | |
|
Diamondback Acquisition, Inc.
✚
|
0.0 | |
|
Canamed, Inc.
✚
|
0.0 |